Related Experiment Video
Updated: May 3, 2026

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells
Published on: May 19, 2020
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India
Lekha Pandit1, Rashmi Kundapur2
1KS Hegde Medical Academy, Nitte University, Mangalore, India panditmng@gmail.com.
Abstract:
There is a dearth of epidemiological data about multiple sclerosis (MS) and related demyelinating disorders in India. In this study, a registry method was used for collecting data from secure sources and the index cases were verified Seventy nine patients were identified . A crude prevalence of 8.3/100,000 was obtained for MS and 6.2/100,000 for clinically-isolated syndrome (CIS). Age-standardized prevalence of MS relative to the world population was 7.8/100,000. Neuromyelitis optica (NMO) and spectrum disorders (NMOS) constituted 13.9% of all demyelinating disorders, with a prevalence of 2.6/100,000. Larger studies with more refined survey methodologies are required to understand the true prevalence of demyelinating disorders in India.
Insights
This study provides initial epidemiological data on multiple sclerosis (MS) and related demyelinating disorders in India, revealing a crude prevalence of 8.3/100,000 for MS. Further research is needed to determine the true prevalence of these neurological conditions.
Area of Science:
- Neurology
- Epidemiology
Background:
- Limited epidemiological data exists for multiple sclerosis (MS) and related demyelinating disorders in India.
- Understanding the prevalence of these conditions is crucial for public health planning and resource allocation.
Purpose of the Study:
- To estimate the prevalence of multiple sclerosis (MS), clinically-isolated syndrome (CIS), and Neuromyelitis Optica Spectrum Disorders (NMOSD) in India.
- To establish a baseline for future epidemiological studies on demyelinating disorders in the region.
Main Methods:
- A registry-based method was employed to collect data from secure sources.
- Index cases were verified, and a total of 79 patients with demyelinating disorders were identified.
Main Results:
- The crude prevalence for MS was found to be 8.3/100,000, and for CIS, it was 6.2/100,000.
- Age-standardized prevalence of MS relative to the world population was 7.8/100,000.
- Neuromyelitis Optica (NMO) and spectrum disorders (NMOS) accounted for 13.9% of all demyelinating disorders, with a prevalence of 2.6/100,000.
Conclusions:
- This study provides the first epidemiological estimates for MS and related disorders in India.
- Larger studies utilizing more refined survey methodologies are necessary to ascertain the precise prevalence of demyelinating disorders across India.
More Related Videos
08:17Author Spotlight: Unveiling the Pathway Linking Obesity to Autoimmune Inflammation in Multiple Sclerosis
Published on: February 23, 2024
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Viral Meningitis
Arboviral Encephalitis
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...